V. Olié, F. Chin, D. Peretti, and C. La, Patients hospitalisés et mortalité en France en 2010, vol.38, 2013.

;. Esc-committee-for-practice-guidelines, . Cpg), J. L. Zamorano, S. Achenbach, H. Baumgartner et al., ESC Guidelines on the diagnosis and management of acute pulmonary embolismThe Task Force for the Diagnosis and Management of Acute Pulmonary Embolism of the European Society of Cardiology (ESC)Endorsed by the, 2014.

, Eur Heart J, vol.35, issue.43, pp.3033-73, 2014.

M. Righini, P. Roy, G. Meyer, F. Verschuren, D. Aujesky et al., The Simplified Pulmonary Embolism Severity Index (PESI): validation of a clinical prognostic model for pulmonary embolism, J Thromb Haemost. 17 août, vol.9, issue.10, pp.2115-2122, 2011.
URL : https://hal.archives-ouvertes.fr/hal-00677151

A. Delluc, L. Ven, F. Mottier, D. , L. Gal et al., Épidémiologie et facteurs de risque de la maladie veineuse thromboembolique, Rev Mal Respir. 1 févr, vol.29, issue.2, pp.254-66, 2012.

C. Kearon, E. A. Akl, J. Ornelas, A. Blaivas, D. Jimenez et al., Antithrombotic Therapy for VTE Disease, CHEST. 1 févr, vol.149, issue.2, pp.315-52, 2016.

. Egeberg, Inherited antithrombin deficiency causing thrombophilia, Thromb Diath Haemorrh, vol.13, pp.516-546, 1965.

S. C. Christiansen, S. C. Cannegieter, T. Koster, J. P. Vandenbroucke, and F. R. Rosendaal, Thrombophilia, clinical factors, and recurrent venous thrombotic events, JAMA. 18 mai, vol.293, pp.2352-61, 2005.

W. Ho, G. J. Hankey, D. J. Quinlan, and J. W. Eikelboom, Risk of recurrent venous thromboembolism in patients with common thrombophilia: A systematic review, Arch Intern Med. 10 avr, vol.166, issue.7, pp.729-765, 2006.

M. Coppens, J. H. Reijnders, S. Middeldorp, C. J. Doggen, and F. R. Rosendaal, Testing for inherited thrombophilia does not reduce the recurrence of venous thrombosis, J Thromb Haemost. 18 août, vol.6, issue.9, pp.1474-1481, 2008.

B. Trevor, G. Elaine, G. Mike, H. Beverley, J. et al., Clinical guidelines for testing for heritable thrombophilia, Br J Haematol. 22 mars, vol.149, issue.2, pp.209-229, 2010.

S. M. Stevens, S. C. Woller, K. A. Bauer, R. Kasthuri, M. Cushman et al., Guidance for the evaluation and treatment of hereditary and acquired thrombophilia, J Thromb Thrombolysis, vol.41, pp.154-64, 2016.

A. J. Kwon, M. Roshal, and M. Desancho, Clinical adherence to thrombophilia screening guidelines at a major tertiary care hospital, J Thromb Haemost. 8 févr, vol.14, issue.5, pp.982-988, 2016.

P. Christopher, M. Heidemann-lauren, M. Megan, D. Paul, and C. Vineet, Inpatient inherited thrombophilia testing, J Hosp Med, vol.11, issue.11, pp.801-805, 2016.

D. Samim, P. Marques-vidal, L. Alberio, G. Waeber, and M. Méan, Do hospital doctors test for thrombophilia in patients with venous thromboembolism?, J Thromb Thrombolysis

, Recommendations on Testing for Thrombophilia in Venous Thromboembolic Disease: a French Consensus Guideline, J Mal Vasc. 1 mai, vol.34, issue.3, pp.156-203, 2009.

C. Kearon, W. Ageno, S. C. Cannegieter, B. Cosmi, G. Geersing et al., Categorization of patients as having provoked or unprovoked venous thromboembolism: guidance from the SSC of ISTH, J Thromb Haemost. 15 avr, vol.14, issue.7, pp.1480-1483, 2016.

V. Annexe, Profil du patient pour lequel les experts changent d'avis entre le temps 1 et le temps 2 après redéfinition de 2 groupes de traitement (3 à 6 mois vs long cours

, Pas de divergence Divergence p-value Sexe -Femme, n (%), vol.87, p.3